Appearance of polymeric forms of Aβ in CSF and blood is a unique feature of AD, and recent data reviewed above [73,77] indicate that analysis of AβO levels possesses a great potential for discriminating between AD and other types of neurodegenerative and neurological disorders with sufficient sensitivity and specificity. Here, ABO is linked to Alzheimer disease.